Washington Report
2012: A Breakthrough Year for New Drugs
The Food and Drug Administration hit a 16-year high 2012, approving 39 new drugs, building on a continued rise in commercial INDs. Moreover, there's no more drug lag with Europe. Jill Wechsler reports ...Read more
Digital Pharma
Should CEOs Use Social Media?
There has been a flurry of reports over the last six months about the C-suite’s engagement with social media. Some hail the arrival of the social CEO, others ask: “Where are they all?"...Read More
Obamacare
Getting it Done in Washington
For his fifth State of the Union address, President Obama hit many familiar themes — including a line about ending certain subsidies to pharmaceutical companies — and emphasized, repeatedly, the need to get things done on the policy front. Will the shadow of sequestration push the 113 Congress to meet Obama's mantra? ...Read more
Leveraging New Pharma Technologies to Improve the Customer Experience
LIVE WEBCAST: Wednesday, February 27, 2013 at 2:00 PM to 3:00PM EST
Register Free at:  www.pharmexec.com/experience
Regulatory
The Sunshine Act: Cloudier Still
With the recent release of the Patient Protection Sunshine Act (PPSA), the Center for Medicare and Medicaid Services (CMS) has established reporting requirements to ensure that drug manufacturers properly disclose payments to physicians. However, a key uncertainty is the issue of state pre-emption ...Read more
Leadership
Pharm Exec's Emerging Pharma Leaders 2013
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today ...Read more
Your View
Take Our New Survey
How do you think pharma’s reputation has changed in recent years? ...Read more
Global
Read the New Pharm Exec Global Digest
In the February issue: Is there a global policy gap on cancer? – What exactly is CLM? – Gamification explained – The impact of the Syrian crisis on pharma ...Read more
|
